Jan Lichtenberg is an entrepreneur and the Chief Executive Officer of InSphero and Syndya Therapeutics. He is passionate about translating groundbreaking scientific discoveries into valuable products, especially in the realm of 3D cell culture and organ-on-a-chip technology. His goal is to facilitate the development of pharmaceutical therapies without relying on animal testing. With a 20-year history in the biotechnology and medical device industry, he collaborates with leading pharmaceutical companies and biotech firms, expediting research and development efforts for safer and more effective drugs. Additionally, he contributes actively to the progress of pharmaceutical and biomedical research as a volunteer Board Member at the Society of Laboratory Automation and Screening, and he serves as a mentor for startups.